Related Experiment Video
Updated: Jun 22, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
The E2F family and the role of E2F1 in apoptosis
Zhenlong Wu1, Shunsheng Zheng, Qiang Yu
1Cancer Biology and Pharmacology, Genome Institute of Singapore, A*Star (Agency for Science, Technology and Research), Biopolis 02-01, Singapore 138672, Singapore.
Abstract:
The E2F family of transcription factors plays a pivotal role in the regulation of cellular proliferation and differentiation. Although the deregulation of E2Fs is considered an oncogenic event that predisposes immortalized cells to transformation, paradoxically, E2F1 is also equipped with an ability to induce apoptosis under certain cellular contexts. It has become evident that E2Fs, in particular E2F1, participate in many aspects of the apoptotic process, either by acting alone or in cooperation with other factors, such as p53, to protect organisms from tumor development in the face of oncogenic lesions. Given the frequent inactivation of p53 in human cancers, the E2F1-induced apoptosis pathway is rapidly gaining attention as a key mechanism to compensate the loss of p53 in human tumors. In this review, we will focus on the recent progress in our understanding of E2F1-mediated apoptosis and discuss how these discoveries can be translated into potential therapeutic intervention.
Insights
Transcription factors E2F1 regulate cell growth and can trigger apoptosis, a programmed cell death. This E2F1-mediated apoptosis pathway is crucial for preventing tumors, especially when p53 is inactivated in cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- The E2F family of transcription factors is critical for controlling cell proliferation and differentiation.
- While E2F deregulation is oncogenic, E2F1 paradoxically induces apoptosis in specific contexts.
- E2F1's role in apoptosis is significant, acting independently or with factors like p53 to prevent tumor development.
Purpose of the Study:
- To review recent advancements in understanding E2F1-mediated apoptosis.
- To explore the therapeutic potential of targeting the E2F1 apoptosis pathway.
- To highlight E2F1's compensatory role in p53-deficient human cancers.
Main Methods:
- Literature review of recent research on E2F1 and apoptosis.
- Analysis of E2F1's mechanisms in inducing programmed cell death.
- Discussion of potential therapeutic strategies targeting E2F1-mediated apoptosis.
Main Results:
- E2F1 plays a multifaceted role in apoptosis, contributing to tumor suppression.
- The E2F1-induced apoptosis pathway is increasingly recognized as vital for compensating for p53 loss in cancers.
- Recent studies reveal novel insights into the molecular mechanisms governing E2F1's apoptotic functions.
Conclusions:
- E2F1-mediated apoptosis is a key cellular defense against oncogenic transformation.
- Targeting E2F1 apoptosis pathways offers promising therapeutic avenues for human cancers, particularly those with p53 inactivation.
- Further research into E2F1's complex roles can unlock new cancer treatment strategies.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Negative Regulator Molecules
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal